Synthesis and radioprotective study of new siladithioacetals and germadithioacetals

Applied Organometallic Chemistry

Volumn 17, Issue 8, 2003, Pages 561-569

  Célariès, Benoît ^a   Amourette, Christine ^b   Lion, Claude ^c   Rima, Ghassoub ^a  

^a UMR 5069) 118 route de Narbonne   (France)

^b CENTRE DE RECHERCHES   (France)

^c UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

Germadithioacetals; LD50; Naphthylethylimidazoline; Radioprotective activity; Siladithioacetals; Toxicity

Indexed keywords

2 [1 (1 NAPHTHYL)ETHYL] 2 IMIDAZOLINE; ACETAL DERIVATIVE; CYSTEAMINE DERIVATIVE; GERMANIUM; MERCAPTAMINE; METHYLCYSTEAMINE; ORGANOGERMANIUM COMPOUND; ORGANOMETALLIC COMPOUND; ORGANOSILICON DERIVATIVE; SILICON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; LD 50; LETHAL DOSE; MALE; MOUSE; NONHUMAN; RADIATION DOSE; RADIATION PROTECTION; SURVIVAL; WHOLE BODY RADIATION;

EID: 0041765040     PISSN: 02682605     EISSN: None     Source Type: Journal    
DOI: 10.1002/aoc.472     Document Type: Article

References (53)

1. Atassi G. Rev. Silicon Germanium Tin Lead Compd. 1985; 8(2-3): 219.
2. Thayer JS. Rev. Silicon Germanium Tin Lead Compd. 1985; 8(2-3): 133.
3. Thayer JS. Appl. Organometal. Chem. 1987; 1(3): 227.
4. Meinema HA, Liebregts AMJ, Budding HA, Bulten EJ. Rev. Silicon Germanium Tin Lead Compd. 1985; 8(2-3): 157.
5. Gar TK, Dombrova OA, Ivashchenko DA, Mironov VF. Izv. Akad. Nauk Ser. Khim. 1993; 10: 1793.
6. Sijpesteijn AK, Rijkens F, van der Kerk GJM, Manten A. J. Microbiol. Serol. 1964; 30(2): 113.
7. Lukevics E, Ignatovich L. Appl. Organometal. Chem. 1992; 6: 113.
8. Lukevics E, Ignatovich L, Shilina N, Germane S. Appl. Organometal. Chem. 1992; 6: 261.
9. Sijpesteijn AK, Rijkens F, van der Kerk GJM, Manten A. Nature 1964; 201: 736.
10. Hachisu M, Takahashi H, Koeda T, Sekizawa Y. J. Pharmacobiodyn. 1983; 6: 814.
11. Aso H, Suzuki F, Yamaguchi T, Hayashi Y, Ebina T, Ishida N. Microbiol. Immunol. 1985; 29: 65.
12. Badger AM, Mirabelli CK, DiMartino M. Immunopharmacology 1985; 10: 201.
13. Brenner DE, Rosenshein NB, Dillon M, Jones HW, Forastiere A, Tipping S, Burnett LS, Greco FA, Wiernik PH. Cancer Treat. Rep. 1985; 69: 457.
14. Eisenhauer E, Quirt I, Connors JM, Maroun J, Skillings J. Invest. New Drugs 1985; 3: 307.
15. Suzuki F. Gan to Kagaku Ryoho 1985; 12: 1445.
16. Kobayashi H, Komuro T, Furue H. Gan to Kagaku Ryoho 1986; 13: 2588.
17. Suzuki F, Brutkiewicz RR, Pollard RB. Anticancer Res. 1986; 6:177.
18. Boros L, Tsiatis AA,Neiman RS,Mann RB,Glick JH. CancerTreat. Rep. 1986; 70: 917.
19. DiMartino MJ, Lee JC, Badger AM, Muirhead KA, Mirabelli CK, Hanna N. J. Pharmacol. Exp. Ther. 1986; 236: 103.
20. Goodman S. J. Comp. Med. 1987; 4: 34.
21. Sato H, Iwaguchi T. Cancer Chemother. 1979; 6: 79.
22. Satgé J, Cazes A, Bouchaut M, Fatôme M, Sentenac-Roumanou H, Lion C. Eur. J. Med. Chem. 1982; 17: 433.
23. Fatôme M, Sentenac-Roumanou H, Lion C, Satgé J, Fourtinon M, Rima G. Eur. J. Med. Chem. 1984; 19: 119.
24. Fatôme M, Sentenac-Roumanou H, Lion C, Satgé J, Rima G. Eur. J. Med. Chem. 1988; 23: 257.
25. Satgé J, Rima G, Fatôme M, Sentenac-Roumanou H, Lion C. Eur. J. Med. Chem. 1989; 24: 48.
26. Rima G, Satgé J, Fatôme M, Laval JD, Sentenac-Roumanou H, Lion C, Lazraq M. Eur. J. Med. Chem. 1991; 26: 291.
27. Rima G, Satgé J, Sentenac-Roumanou H, Fatôme M, Lion C, Laval JD. Eur. J. Med. Chem. 1993; 28: 761.
28. Rima G, Satgé J, Sentenac-Roumanou H, Fatôme M, Laval JD, Lion C, Alazard O, Chabertier P. Appl. Organometal. Chem. 1994; 8: 481.
29. Rima G, Satgé J, Sentenac-Roumanou H, Fatôme M, Laval JD, Lion C, Dagiral R. Appl. Organometal. Chem. 1996; 10: 113.
30. Rima G, Satgé J, Sentenac-Roumanou H, Fatôme M, Laval JD, Lion C, Thiriot C, Dagiral R, Martín C. Main Group Met. Chem. 1997; 20(4): 255.
31. Rima G, Satgé J, Dagiral R, Lion C, Fatôme M, Roman V, Laval JD. Metal-Based Drugs 1998; 5(3): 139.
32. Rima G, Satgé J, Dagiral R, Lion C, Sentenac-Roumanou H, Fatôme M, Roman V, Laval JD. Metal-Based Drugs 1999; 6(1): 49.
33. Rima G, Satgé J, Dagiral R, Lion C, Fatôme M, Roman V, Laval JD. Appl. Organometal. Chem. 1999; 13: 583.
34. Célariès B, Rima G, Court L, Lion C, Roman V, Laval JD. Metal-Based Drugs 2001; 8(4): 199.
35. Célariès B, Court L, Lion C, Rima G, Roman V. Main Group Met. Chem. 2001; 25(1): 58.
36. Bonet-Maury P, Patti F. J. Radiol. Electrol. Arch. Electr. Med. 1950; 31: 286.
37. Finney DJ. Probit Analysis. Cambridge University Press: Cambridge, 1947.
38. Lesbre M, Mazerolles P, Satgé J. In The Organic Compounds of Germanium. John Wiley and Sons Ltd: New York, 1973.
39. Satgé J, Lesbre M, Baudet M. C. R. Acad. Sci. Paris. Ser. C 1964; 259: 4733.
40. Satgé J, Baudet M. C. R. Acad. Sci. Paris. Ser. C 1966; 263: 435.
41. Corbin J, Miller KF, Pariyadath N, Wherland S, Bruce AE, Stiefel EI. Inorg. Chim. Acta 1984; 90: 41.
42. Kakimoto N, Matsui M, Takada T, Akida M. Heterocycles 1985; 23(10): 2681.
43. Tacke R, Becker B, Berg D, Brandes W, Dutzmann S, Schaller K. J. Organometal. Chem. 1992; 438: 45.
44. Lukevics E, Germane S, Ignatovich L. Appl. Organometal. Chem. 1992; 6: 543.
45. Anger F, Anger JP, Guillou L, Papillon A. Appl. Organometal. Chem. 1992; 6: 267.
46. Tacke R, Reichel D, Jones PG, Hou X, Waelbroeck M, Gross J, Mutschler E, Lambrecht G. J. Organometal. Chem. 1996; 521: 305.
47. Lukevics E, Veveris V, Dirnens V. Appl. Organometal. Chem. 1997; 11: 805.
48. Lukevics E, Ignatovich L, Germane S. Khim. Geterotsikl. Soed. 1995; 10: 1412.
49. Lukevics E, Ignatovich L. Main Group Met. Chem. 1994; 1: 133.
50. Lukevics E, Gar TK, Ignatovich L, Mironov F. Biological Activity of the Germanium Compounds. Zinatne: Riga, USSR, 1990; 191.
51. Li F, Zhang Z, Gao H. Metal-Based Drugs 1996; 5: 241.
52. Lukevics E, Arsenyan P, Veveris M. Metal-Based Drugs 1998; 5(4): 251.
53. Lukevics E, Ignatovich L. Biological activity of organogermanium compounds. In The Chemistry of Organic Germanium, Tin and Lead Compounds, vol. 2. John Wiley and Sons Ltd: Chichester, 2002; 1653.